-
CPHI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
China Pharma (CPHI)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 718.69 k | 718.69 k | 718.69 k | 718.69 k | 718.69 k | 718.69 k |
Cash burn (monthly) | 6.88 k | 15.27 k | 372.64 k | 380.49 k | 15.65 k | (no burn) |
Cash used (since last report) | 19.41 k | 43.07 k | 1.05 mm | 1.07 mm | 44.15 k | n/a |
Cash remaining | 699.28 k | 675.62 k | -332.45 k | -354.59 k | 674.54 k | n/a |
Runway (months of cash) | 101.6 | 44.3 | -0.9 | -0.9 | 43.1 | n/a |
13F holders | Current |
---|---|
Total holders | 6 |
Opened positions | 5 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 24.04 mm |
Total shares | 5.31 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Streeterville Capital | 5.16 mm | $0.00 |
Renaissance Technologies | 63.85 k | $22.00 k |
Millennium Management | 36.67 k | $12.51 mm |
Virtu Financial | 21.31 k | $7.00 k |
Two Sigma Securities | 19.21 k | $6.55 mm |
Bridgeway Capital Management | 14.50 k | $4.95 mm |
Proequities | 0.00 | $0.00 |